PUBLICATIONS

Publications in Academic Journals

2020

Feng X, Kim DD, Cohen JT, Neumann PJ, Ollendorf DA. Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter? Int J Technol Assess Health Care. 2020; 36(2):96-103.  [PMID 32340631]

Leech AA, Kim DD, Cohen JT, Neumann PJ. Are low and middle-income countries prioritizing high-value healthcare interventions? BMJ Glob Health. 2020; 5:e001850. [PMID 32133187]

Panzer AD, Emerson JG, D'Cruz B, et al. Growth and capacity for cost-effectiveness analysis in Africa. Health Econ. 2020; Epub ahead of print. [PMID 32412153]

2019

Butt T, Liu GG, Kim DD, Neumann PJ. Taking stock of cost-effectiveness analysis of healthcare in China. BMJ Glob Health. 2019;4(3):e001418. [PMID 32412153]

Emerson J, Panzer A, Cohen JT, et al.  Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS One. 2019;14(5): e0205633. [PMID 31042714

2018

Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value Health. 2018;21(7):759–61 [PMID 30005746]

Neumann PJ, Anderson JE, Panzer AD, et al. Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures. Gates Open Res. 2018;2:5. [PMID 29431169]

2017

Bilinski A, Neumann P, Cohen J, Thorat T, McDaniel K, Salomon JA. When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs. PLoS Med. 2017;14(10):e1002397. [PMID 28847014]

Cohen JT, Neumann PJ, Wong JB. A Call for Open-Source Cost-Effectiveness Analysis. Ann Intern Med. 2017;167(6):432-433. [PMID 29028754]

Cohen JT, Wong JB.  Can economic model transparency improve provider interpretation of cost-effectiveness analysis?  A response.  Med Care. 2017;55(11):912–914. [PMID 29028754]

2016

Neumann PJ, Thorat T, Zhong Y, et al. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted. PLoS One. 2016;11(12):e0168512. [PMID 28005986]

Teerawattananon Y, Tantivess S, Yamabhai I, et al. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh. Health Res Policy Syst. 2016;14(1):86. [PMID 27912780]

Technical Reports

Emerson, J. and Kim, D.D. (2018). Disability-Adjusted Life Year Conversion, Case Study #1: HIV Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA  [Link to download]

Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #2: Dengue Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA  [Link to download]

Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #3: Tuberculosis Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA  [Link to download]

Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #4: Coronary Heart Disease Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA  [Link to download]

Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #5: Postpartum Hemorrhage Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA  [Link to download]